Requests for Specimen Verification will only be accepted from November 15, 2020 to January 13, 2021. If you plan to submit a grant application this cycle, an approved Request for Specimen Verification is required. Once your Request for Specimen Verification has been approved, you will receive a confirmation letter to accompany your grant application.

The grant application deadline is February 11, 2021.

Information is available regarding the PLCO trial and PLCO biospecimens

Please visit the PAR Request Form for Specimen Verification page to preview instructions about the process, review the Policies and Procedures, and begin a Request for Specimen Verification.

If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

Data for published PLCO EEMS studies are being published on CDAS on a weekly basis as they are released. New results search functionality has been implemented to easily search the available analytes. https://cdas.cancer.gov/learn/plco/lab-results/browse/

Please note, for each of these studies markers were measured independently using various platforms as referenced in their corresponding publications. The publications can be found by clicking on the study ID for each project. Please use caution when pooling data across different case-control studies.

You can learn more about the available The Minnesota Colon Cancer Control Study data at https://cdas.cancer.gov/minn/.

The following Early Phase Prevention Trials data is now available. You can learn more about these trials at cdas.cancer.gov/eppt/ and request access to the data here.

Phase I Trial of Berberine in Subjects with Ulcerative Colitis (NWU2014-03-01)

Phase Ib Biomarker Trial of Naproxen in patients at risk for DNA Mismatch Repair Deficient Colorectal Cancer (MDA2013-01-02)

You can learn more about the available Memorial Sloan-Kettering Lung Study data at https://cdas.cancer.gov/mem/.